RAL · XBRL financial data
Ralliant financial statements, every quarter
The same tables from 5 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal quarters (RAL's year ends in late December)
| In millions of dollars | Jun 27, 2025 | Sep 26, 2025 | Dec 31, 2025 | Apr 3, 2026 | Jul 3, 2026 |
|---|---|---|---|---|---|
| Revenue from contracts with customers | 503 | 529 | 555* | 535 | 568 |
| Cost of goods and services sold | 255 | 261 | 275* | 262 | 275 |
| Gross profit | 248 | 269 | 280* | 272 | 293 |
| Research and development | 42 | 39 | 43* | 44 | 45 |
| Selling, general and administrative | 147 | 178 | 163* | 161 | 166 |
| Total operating expenses | 189 | 217 | 206* | 204 | 211 |
| Operating income (loss) | 59 | 52 | (1,368)* | 68 | 82 |
| Interest expense | 0 | 16 | 16* | 15 | 14 |
| Other income (expense) | 0 | (1) | 0* | (1) | 0 |
| Income tax expense (benefit) | 11 | (5) | (10)* | 9 | 11 |
| Net income (loss) | 48 | 40 | (1,374)* | 44 | 57 |
| Earnings per share, basic USD per share | 0.42 | 0.35 | (12.16)* | 0.39 | 0.51 |
| Earnings per share, diluted USD per share | 0.42 | 0.35 | (12.22)* | 0.39 | 0.51 |
| Weighted average shares, basic millions of shares | 113 | 113 | 113* | 112 | 111 |
| Weighted average shares, diluted millions of shares | 113 | 113 | 112* | 113 | 113 |
Balance sheet
CSVFiscal quarters (RAL's year ends in late December)
| In millions of dollars | Jun 27, 2025 | Sep 26, 2025 | Dec 31, 2025 | Apr 3, 2026 | Jul 3, 2026 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 199 | 264 | 319 | 268 | 271 |
| Accounts receivable | 289 | 310 | 285 | 277 | 292 |
| Inventory | 299 | 303 | 302 | 321 | 337 |
| Prepaid and other current assets | 60 | 100 | 70 | 63 | 72 |
| Total current assets | 847 | 977 | 976 | 930 | 972 |
| Property and equipment, net | 209 | 212 | 214 | 215 | 214 |
| Right-of-use asset | 71 | 70 | 68 | 74 | 71 |
| Goodwill | 3,119 | 3,113 | 1,672 | 1,617 | 1,615 |
| Total assets | 5,177 | 5,265 | 3,822 | 3,697 | 3,706 |
| Accrued liabilities | 293 | 214 | 366 | 330 | 361 |
| Current portion of long-term debt | — | — | 530 | 0 | 0 |
| Total current liabilities | 533 | 657 | 1,160 | 579 | 638 |
| Long-term debt | 1,149 | 1,149 | 618 | 1,148 | 1,149 |
| Lease liability, non-current | — | — | 58 | — | — |
| Total liabilities | — | — | 2,187 | 2,131 | 2,172 |
| Retained earnings (accumulated deficit) | — | 34 | (1,345) | (1,307) | (1,255) |
| Total stockholders' equity | 3,040 | 2,964 | 1,634 | 1,566 | 1,534 |
| Total liabilities and equity | 5,177 | 5,265 | 3,822 | 3,697 | 3,706 |
| Common shares outstanding (cover page) millions of shares | 113 | 113 | 112 | 112 | 111 |
Cash flows
CSVFiscal quarters (RAL's year ends in late December)
| In millions of dollars | Jun 27, 2025 | Sep 26, 2025 | Dec 31, 2025 | Apr 3, 2026 | Jul 3, 2026 |
|---|---|---|---|---|---|
| Net income (loss) | 48 | 40 | (1,374)* | 44 | 57 |
| Stock-based compensation | 8* | 31* | 10* | 11 | 12* |
| Depreciation and amortization | 29 | 30 | 30* | 30 | 30 |
| Net cash from operating activities | 85* | 139* | 102* | 19 | 106* |
| Purchases of property and equipment | 12* | 12* | 10* | 9 | 6* |
| Net cash from investing activities | (12)* | (12)* | (10)* | (9) | (6)* |
| Share repurchases | 0* | — | — | 51 | 101* |
| Dividends paid | 0* | 6* | 6* | 6 | 6* |
| Proceeds from long-term debt | — | 0* | 0* | — | — |
| Net cash from financing activities | 117* | (61)* | (38)* | (59) | (97)* |
| Net change in cash | 199* | 66* | 55* | (51) | 3* |
Compare with peers
SIC 3823 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3823 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Ralliant | 271 | 568 | 106* | 110.6M | — | 10-QJul 3, 2026 |
| Bio-Rad Laboratories | 517 | 651 | 99* | not reported | — | 10-QJun 30, 2026 |
| Bruker | 185 | 839 | (77)* | 152.4M | 2.4 quarters | 10-QJun 30, 2026 |
| Sensata Technologies Holding | 553 | 1,004 | 225* | 145.6M | — | 10-QSep 30, 2026 |
| Mirion Technologies | 409 | 278 | 59* | not reported | — | 10-QSep 30, 2026 |
| Onto Innovation | 1,253 | 343 | 62* | 49.1M | — | 10-QJun 30, 2026 |
| Cognex | 303 | 291 | 69* | 168.2M | — | 10-QJul 5, 2026 |
| Vontier | 266 | 757 | 116* | 135.2M | — | 10-QJul 3, 2026 |
| Itron | 840 | 599 | 102* | 43.9M | — | 10-QSep 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.